Apollon Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.2M | Buy |
29,757
+4,630
| +18% | +$2.06M | 0.26% | 73 |
|
|
2025
Q1 | $12.2M | Buy |
25,127
+12,955
| +106% | +$6.28M | 0.27% | 76 |
|
|
2024
Q4 | $4.9M | Buy |
12,172
+3,976
| +49% | +$1.6M | 0.11% | 160 |
|
|
2024
Q3 | $3.81M | Buy |
8,196
+793
| +11% | +$369K | 0.11% | 166 |
|
|
2024
Q2 | $3.47M | Buy |
7,403
+313
| +4% | +$147K | 0.11% | 173 |
|
|
2024
Q1 | $2.96M | Buy |
7,090
+730
| +11% | +$305K | 0.09% | 201 |
|
|
2023
Q4 | $2.59M | Buy |
6,360
+1,435
| +29% | +$584K | 0.09% | 207 |
|
|
2023
Q3 | $1.71M | Buy |
4,925
+378
| +8% | +$131K | 0.09% | 227 |
|
|
2023
Q2 | $1.6M | Buy |
4,547
+116
| +3% | +$40.8K | 0.08% | 264 |
|
|
2023
Q1 | $1.4M | Sell |
4,431
-231
| -5% | -$72.8K | 0.09% | 244 |
|
|
2022
Q4 | $1.35M | Buy |
4,662
+711
| +18% | +$205K | 0.1% | 224 |
|
|
2022
Q3 | $1.14M | Buy |
3,951
+598
| +18% | +$173K | 0.09% | 221 |
|
|
2022
Q2 | $945K | Buy |
3,353
+357
| +12% | +$101K | 0.08% | 274 |
|
|
2022
Q1 | $782K | Buy |
2,996
+551
| +23% | +$144K | 0.06% | 347 |
|
|
2021
Q4 | $537K | Buy |
+2,445
| New | +$537K | 0.04% | 444 |
|
|
2020
Q3 | – | Sell |
-16
| Closed | -$5K | – | 671 |
|
|
2020
Q2 | $5K | Buy |
+16
| New | +$5K | ﹤0.01% | 569 |
|